1. Home
  2. REKR vs RFL Comparison

REKR vs RFL Comparison

Compare REKR & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rekor Systems Inc.

REKR

Rekor Systems Inc.

HOLD

Current Price

$0.69

Market Cap

97.7M

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$2.23

Market Cap

92.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
REKR
RFL
Founded
2017
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Real Estate
Sector
Telecommunications
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
97.7M
92.6M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
REKR
RFL
Price
$0.69
$2.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.2M
364.7K
Earning Date
05-13-2026
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
4.35
28.28
EPS
N/A
N/A
Revenue
$9,234,000.00
$917,000.00
Revenue This Year
$12.51
N/A
Revenue Next Year
$23.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.96
52 Week Low
$0.60
$1.12
52 Week High
$3.42
$3.96

Technical Indicators

Market Signals
Indicator
REKR
RFL
Relative Strength Index (RSI) 48.57 46.75
Support Level $0.60 $1.21
Resistance Level $0.74 $3.96
Average True Range (ATR) 0.04 0.38
MACD 0.01 -0.13
Stochastic Oscillator 67.41 4.42

Price Performance

Historical Comparison
REKR
RFL

About REKR Rekor Systems Inc.

Rekor Systems Inc is a roadway intelligence company focused on modernizing public safety, urban mobility, and transportation management through solutions. The company delivers services and solutions that collect, connect, and organize mobility data, providing real-time insights to support decision making, enhance situational awareness, enable rapid response, and support predictive analytics. The Company derives its revenues mainly from the licensing and sale of its roadway data and traffic management product and service offerings. These offerings include a mixture of data collection, implementation, engineering, customer support, and maintenance services, as well as software and hardware. The company operates in the United States and other regions.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: